IGF1R and Ewing sarcoma: We found that combinatorial therapy of PPP1R1A inhibition with an IGF-1R inhibitor was more effective not only in limiting primary xenograft tumor growth, but also in decreasing lung metastasis, demonstrating a promising specific strategy to treat both primary and metastatic ES.